Dentsply International Inc. (NASDAQ:XRAY) – Equities research analysts at William Blair lifted their Q4 2016 earnings estimates for shares of Dentsply International in a research report issued to clients and investors on Monday. William Blair analyst J. Kreger now anticipates that the firm will post earnings per share of $0.65 for the quarter, up from their prior forecast of $0.63. William Blair also issued estimates for Dentsply International’s Q1 2017 earnings at $0.69 EPS, Q2 2017 earnings at $0.82 EPS, Q3 2017 earnings at $0.76 EPS, Q4 2017 earnings at $0.81 EPS, FY2017 earnings at $3.08 EPS and FY2018 earnings at $3.48 EPS.

Several other research analysts have also weighed in on the stock. Zacks Investment Research lowered shares of Dentsply International from a “hold” rating to a “sell” rating in a research note on Wednesday, November 2nd. Morgan Stanley upgraded shares of Dentsply International from an “equal weight” rating to an “overweight” rating and boosted their price objective for the stock from $65.00 to $69.00 in a research note on Tuesday, November 1st. They noted that the move was a valuation call. Robert W. Baird restated an “outperform” rating and set a $67.00 price objective (down from $69.00) on shares of Dentsply International in a research note on Tuesday, October 4th. JPMorgan Chase & Co. assumed coverage on shares of Dentsply International in a research note on Thursday, September 22nd. They set a “neutral” rating and a $65.00 price objective on the stock. Finally, Bank of America Corp. assumed coverage on shares of Dentsply International in a research note on Monday, September 12th. They set a “buy” rating and a $70.00 price objective on the stock. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and six have assigned a buy rating to the company’s stock. The company has a consensus rating of “Hold” and a consensus price target of $67.33.

Earnings History and Estimates for Dentsply International (NASDAQ:XRAY)

Dentsply International (NASDAQ:XRAY) opened at 61.08 on Wednesday. Dentsply International has a 52 week low of $53.43 and a 52 week high of $65.83. The firm’s 50-day moving average is $58.93 and its 200-day moving average is $61.06.

Dentsply International (NASDAQ:XRAY) last announced its quarterly earnings results on Friday, November 4th. The company reported $0.66 EPS for the quarter, topping analysts’ consensus estimates of $0.63 by $0.03. The firm earned $954.20 million during the quarter, compared to analysts’ expectations of $967.68 million. Dentsply International had a net margin of 11.15% and a return on equity of 8.04%. The company’s revenue for the quarter was up 47.0% compared to the same quarter last year. During the same quarter last year, the company earned $0.66 earnings per share.

The firm also recently disclosed a dividend, which was paid on Friday, October 14th. Shareholders of record on Friday, September 30th were issued a $0.0775 dividend. The ex-dividend date of this dividend was Wednesday, September 28th. Dentsply International’s dividend payout ratio is currently 15.98%.

In other Dentsply International news, VP Rainer Berthan sold 5,000 shares of the business’s stock in a transaction dated Tuesday, September 6th. The shares were sold at an average price of $61.12, for a total value of $305,600.00. Following the completion of the sale, the vice president now owns 34,370 shares of the company’s stock, valued at approximately $2,100,694.40. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, SVP Maureen J. Macinnis sold 45,100 shares of the business’s stock in a transaction dated Thursday, August 25th. The shares were sold at an average price of $60.55, for a total transaction of $2,730,805.00. Following the completion of the sale, the senior vice president now directly owns 36,730 shares of the company’s stock, valued at approximately $2,224,001.50. The disclosure for this sale can be found here. 2.20% of the stock is currently owned by company insiders.

A number of hedge funds have recently bought and sold shares of the stock. Checchi Capital Advisers LLC increased its stake in Dentsply International by 2.1% in the second quarter. Checchi Capital Advisers LLC now owns 2,007 shares of the company’s stock worth $125,000 after buying an additional 41 shares in the last quarter. Penserra Capital Management LLC increased its stake in Dentsply International by 100.0% in the third quarter. Penserra Capital Management LLC now owns 2,160 shares of the company’s stock worth $128,000 after buying an additional 1,080 shares in the last quarter. Contravisory Investment Management Inc. increased its stake in shares of Dentsply International by 8.9% in the third quarter. Contravisory Investment Management Inc. now owns 3,108 shares of the company’s stock worth $185,000 after buying an additional 254 shares during the period. Global X Management Co. LLC increased its stake in shares of Dentsply International by 110.1% in the second quarter. Global X Management Co. LLC now owns 3,169 shares of the company’s stock worth $197,000 after buying an additional 1,661 shares during the period. Finally, Baldwin Brothers Inc. MA purchased a new stake in shares of Dentsply International during the third quarter worth $198,000. 94.37% of the stock is owned by hedge funds and other institutional investors.

About Dentsply International

DENTSPLY SIRONA Inc, formerly DENTSPLY International Inc, designs, develops, manufactures and markets a range of consumable dental products for the professional dental market. The Company also manufactures and markets consumable medical device products consisting mainly of urological catheters and certain surgical products.

5 Day Chart for NASDAQ:XRAY

Receive News & Stock Ratings for Dentsply International Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dentsply International Inc. and related stocks with our FREE daily email newsletter.